Anzeige
Mehr »
Montag, 30.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
570 Leser
Artikel bewerten:
(2)

Classworx: ClassWorx Announces Interview with Global WholeHealth Partners Corporation (GWHP) with CEO Charles Strongo, Now Live on YouTube

ATLANTA, GA / ACCESSWIRE / April 26, 2021 / Classworx, Inc. formerly known as Chill N Out Cryotherapy Inc.(OTC PINK:CHNO) a Virtual Directory for instructors, performers and hosts of virtual classes and events on Zoom, has published the interview with Charles Strongo from Global WholeHealth Partners (OTC PINK:GWHP).

The live Zoom interview was held on April 26, 2021 and lasted approximately 23 minutes. In the interview, Charles Strongo discusses FDA Approved Diagnostic Tests.

The interview is now available on the ClassWorx YouTube channel. Follow us on YouTube to watch future interviews.

Classworx offers interviews to company CEOs and Presidents who are interested in telling their stories to the public. To schedule an interview, please contact ClassWorx, Inc. at the contact information listed below.

ClassWorx, Inc. completed its name change with the state of Delaware from Chill N Out Cryotherapy, Inc. to Classworx, Inc. The company filed its name change with FINRA and is awaiting approval.

About Global WholeHealth Partners
Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world.

By so doing, GWHP has led the fight against vector-borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases.

What We Do:
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 1⁄2 hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors.

Mission:
GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs.

Vision Statement:
Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.

Competitive Advantage:
GWHP has partnered with several companies in the health care industry and enjoy the power, resources and availability to vertically integrate. GWHP can identify a new virus and create a specific test within 8 -12 weeks and for a fraction of the cost of its competitors. Global WholeHealth Partners is the only company with the Rapid Diagnostic Kits to test for Ebola and ZIKA.

The Rapid Diagnostic Kits do not have to be refrigerated and last up to 18 months.

About Classworx, Inc. (formerly known as Chill N Out Cryotherapy, Inc.)
Chill N Out Cryotherapy, Inc. (OTC PINK:CHNO), a Delaware Corporation, owns and operates ClassWorx.com. Chill N Out Cryotherapy, Inc. currently trades on the OTC Pinks under the stock symbol CHNO. Classworx provides an internet-based, global network-directory of people offering Virtual classes or events utilizing video conferencing to remotely deliver individual or group instruction in a broad range of disciplines ("virtual classes"). The Company is based in the Atlanta, Georgia, area spans a global outreach through the worldwide web.

Safe Harbor:
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'), including statements regarding potential sales, the success of the company's business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of Chill N Out Cryotherapy, Inc. DBA Classworx to differ materially from those implied or expressed.

Contact:
Raymond Firth
470-448-4734
www.classworx.com

SOURCE: ClassWorx



View source version on accesswire.com:
https://www.accesswire.com/642231/ClassWorx-Announces-Interview-with-Global-WholeHealth-Partners-Corporation-GWHP-with-CEO-Charles-Strongo-Now-Live-on-YouTube

© 2021 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.